Weekes A R, Makanji H H, West C R
Br Med J. 1976 Apr 24;1(6016):987-8. doi: 10.1136/bmj.1.6016.987.
In a prospective study of 52 consecutive women who required acceleration of labour intravenous prostaglandin E2 (PGE2) was used as the oxytocic agent. These mothers were matched for age, parity, height, gestational age, initial cervical dilatation, and station and position of the fetal head with 52 women whose labours were accelerated with oxytocin; both drugs were equally effective. Acceleration to delivery intervals, second-stage durations, the number of assisted deliveries, and Apgar scores were similar regardless of the oxytocic used. Although PGE2 compares well with oxytocin, it offers no further advantages and is more expensive and less well tried than oxytocin.
在一项针对52名连续需要加速产程的女性的前瞻性研究中,静脉注射前列腺素E2(PGE2)被用作催产剂。将这些母亲与52名使用催产素加速产程的女性在年龄、胎次、身高、孕周、初始宫颈扩张程度以及胎儿头部的先露部位和位置方面进行匹配;两种药物的效果相同。无论使用哪种催产剂,加速至分娩的间隔时间、第二产程持续时间、助产分娩次数和阿氏评分都相似。尽管PGE2与催产素相比效果良好,但它没有进一步的优势,而且比催产素更昂贵且应用经验更少。